My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 123

    1.

    Oral thyroxine: variation in biologic action and tablet content.

    Sawin CT, Surks MI, London M, Ranganathan C, Larsen PR.

    Ann Intern Med. 1984 May;100(5):641-5.PMID: 6546843 [PubMed - indexed for MEDLINE]Related articles

    2.

    The equivalency of two L-thyroxine preparations.

    Hennessey JV, Burman KD, Wartofsky L.

    Ann Intern Med. 1985 Jun;102(6):770-3.PMID: 3922270 [PubMed - indexed for MEDLINE]Related articles

    3.

    Biopharmaceutical comparison of two levothyroxine sodium products.

    Blouin RA, Clifton GD, Adams MA, Foster TS, Flueck J.

    Clin Pharm. 1989 Aug;8(8):588-92.PMID: 2504532 [PubMed - indexed for MEDLINE]Related articles

    4.

    Comparative bioavailability of two oral L-thyroxine formulations after multiple dose administration in patients with hypothyroidism and its relation with therapeutic endpoints and dissolution profiles.

    Vaisman M, Spina LD, Eksterman LF, dos Santos MJ, Lima JS, Volpato NM, da Silva RL, de Brito AP, Noël F.

    Arzneimittelforschung. 2001;51(3):246-52.PMID: 11304941 [PubMed - indexed for MEDLINE]Related articles

    5.

    Potency of brand name and generic levothyroxine.

    Stoffer SS, Szpunar WE.

    JAMA. 1980 Oct 10;244(15):1704-5.PMID: 7411829 [PubMed - indexed for MEDLINE]Related articles

    6.

    L-thyroxine dosage: a reevaluation of therapy with contemporary preparations.

    Hennessey JV, Evaul JE, Tseng YC, Burman KD, Wartofsky L.

    Ann Intern Med. 1986 Jul;105(1):11-5.PMID: 3087253 [PubMed - indexed for MEDLINE]Related articles

    7.

    Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans.

    Fish LH, Schwartz HL, Cavanaugh J, Steffes MW, Bantle JP, Oppenheimer JH.

    N Engl J Med. 1987 Mar 26;316(13):764-70.PMID: 3821822 [PubMed - indexed for MEDLINE]Related articles

    8.

    Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.

    Dong BJ, Hauck WW, Gambertoglio JG, Gee L, White JR, Bubp JL, Greenspan FS.

    JAMA. 1997 Apr 16;277(15):1205-13.PMID: 9103344 [PubMed - indexed for MEDLINE]Related articles

    9.

    Pilot study on the absolute and relative bioavailability of Synthroid and Levothroid, two brands of sodium levothyroxine.

    Maxon HR, Ritschel WA, Volle CP, Eldon MA, Chen IW, Fernandez MF, Cline J, Mayfield G.

    Int J Clin Pharmacol Ther Toxicol. 1983 Aug;21(8):379-82.PMID: 6688797 [PubMed - indexed for MEDLINE]Related articles

    10.

    Tablet formulation of levothyroxine is absorbed less well than powdered levothyroxine.

    Yamamoto T.

    Thyroid. 2003 Dec;13(12):1177-81.PMID: 14751040 [PubMed - indexed for MEDLINE]Related articles

    11.

    Bioavailability of thyroid hormones from oral replacement preparations.

    LeBoff MS, Kaplan MM, Silva JE, Larsen PR.

    Metabolism. 1982 Sep;31(9):900-5.PMID: 7121261 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Posologic equivalents of oral L-thyroxine in thyroid insufficiency (120 cases)]

    [No authors listed]

    Ann Med Interne (Paris). 1983;134(7):636-42. French. PMID: 6666901 [PubMed - indexed for MEDLINE]Related articles

    13.

    Thyroid hormone levels after acute L-thyroxine loading in hypothyroidism.

    Valente WA, Goldiner WH, Hamilton BP, Wiswell JG, Mersey JH.

    J Clin Endocrinol Metab. 1981 Sep;53(3):527-9.PMID: 7263838 [PubMed - indexed for MEDLINE]Related articles

    14.

    Thyrotrophin augmentation after commencing thyroxine replacement in primary hypothyroidism.

    Ghose RR, Upadhyay HP.

    Postgrad Med J. 1986 Jan;62(723):11-4.PMID: 3797360 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    L-thyroxine contamination of pharmaceutical D-thyroxine: probable cause of therapeutic effect.

    Young WF Jr, Gorman CA, Jiang NS, Machacek D, Hay ID.

    Clin Pharmacol Ther. 1984 Dec;36(6):781-7.PMID: 6499357 [PubMed - indexed for MEDLINE]Related articles

    16.

    Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyroid patients.

    Sawin CT, Herman T, Molitch ME, London MH, Kramer SM.

    Am J Med. 1983 Aug;75(2):206-9.PMID: 6881172 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparison of the effect of a single oral L-thyroxine dose (150 micrograms) in tablet and in solution on serum thyroxine and TSH concentrations.

    Carpi A, De Gaudio C, Cirigliano G, Toni MG.

    Thyroidology. 1993 Apr;5(1):9-12.PMID: 7508742 [PubMed - indexed for MEDLINE]Related articles

    18.

    Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1-10.0 mIU/L).

    Fatourechi V, Lankarani M, Schryver PG, Vanness DJ, Long KH, Klee GG.

    Mayo Clin Proc. 2003 May;78(5):554-60.PMID: 12744541 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The effect of long-term thyroxine on bone mineral density and serum cholesterol.

    Fowler PB, McIvor J, Sykes L, Macrae KD.

    J R Coll Physicians Lond. 1996 Nov-Dec;30(6):527-32.PMID: 8961207 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.

    Bolk N, Visser TJ, Kalsbeek A, van Domburg RT, Berghout A.

    Clin Endocrinol (Oxf). 2007 Jan;66(1):43-8.PMID: 17201800 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity